India  
 
NewsR.in

United States: FDA Releases Draft Labeling Guidance For Biosimilar Products - Goodwin Procter LLP

Mondaq Saturday, 30 September 2023
Last week, FDA released a draft guidance, "Labeling for Biosimilar and Interchangeable Biosimilar Products" ("2023 Draft Guidance") that—when finalized—will revise and replace its July 2018...
0
shares		ShareTweetSavePostSend
 

You Might Like


Related news from verified sources

United States: Is It Biosimilar Or Interchangeable? It Won't Be Easy To Tell Under FDA's Latest Draft Labeling Guidance - Goodwin Procter LLP

 Last week, FDA released a draft guidance, "Labeling for Biosimilar and Interchangeable Biosimilar Products" that—when finalized—will revise and replace its...
Mondaq

United States: Are You Not Interchanged? FDA's Recent Biosimilar Labeling Guidance Chips Away At Interchangeable Product Advantages - Foley Hoag LLP

 Interchangeable biosimilar products would not be allowed to disclose or explain their interchangeability designations in their products' labels under FDA's new...
Mondaq